In this study, we systematically estimated the effects of 11 021 dynamic gene expression profiles (all termiologies listed in Table 1) during CD4+ T cell activation[21] on six common cancers by developing a new MR pipeline (see Figure1). The gene discussed is CD4; the disease is cancer.